Bruno G De Geest

61PUBLICATIONS
107CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Glycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (61)

|Jun 18, 2026
POLY-Senolytic nanoplatform for tumor-specific eradication of senescent tumor cells and mitigation of radiotherapy-induced immune resistance of cancer.

|May 29, 2026
Multivalent Antibody-Recruiting Molecules for Targeted Immune-Killing of Carbonic Anhydrase IX-Expressing Cancer Cells.

|May 22, 2026
Marker-Agnostic Tumor Anchoring Chimeras Enable pH-Gated Immune Engagement.

|May 11, 2026
Multivalent Antibody-Recruiters Targeting Fibroblast Activation Protein for Innate Immune Killing.

|Apr 03, 2026
Coassembled Prodrug Nanoparticles Mitigating the Acquired Resistance to Protein Degradation Therapy.

Jing Gao, Shumin Lei, Yiying Wang

|Sep 30, 2025
pH-Triggered Cell Surface Anti-Hapten Antibody Recruitment by Amphiphilic Block Copolymers Containing Ionizable Amines and Haptens in the Hydrophobic Block.

Haixia Peng, Benoit Louage, Jamie De Baere

Pageof 11

Frequent Collaborators

9 joint publications

Lutz Nuhn

9 joint publications

Niek Sanders

8 joint publications

Zifu Zhong

7 joint publications

Sunil A David